Patents by Inventor Elizabeth Thiele

Elizabeth Thiele has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF CANNABIDIOL IN THE TREATMENT OF EPILEPSY
    Publication number: 20220323375
    Abstract: The present disclosure relates to the use of cannabidiol (CBD) for the treatment of Tuberous Sclerosis Complex (TSC). In particular the TSC is treatment resistant and is characterised by generalised seizures or focal seizures with impairment. The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs).
    Type: Application
    Filed: June 29, 2022
    Publication date: October 13, 2022
    Inventors: Geoffrey GUY, Stephen WRIGHT, Elizabeth THIELE
  • Use of cannabidiol in the treatment of epilepsy
    Patent number: 11400055
    Abstract: The present disclosure relates to the use of cannabidiol (CBD) for the treatment of Tuberous Sclerosis Complex (TSC). In particular the TSC is treatment resistant and is characterised by generalised seizures or focal seizures with impairment. The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs).
    Type: Grant
    Filed: June 7, 2021
    Date of Patent: August 2, 2022
    Assignee: GW Research Limited
    Inventors: Geoffrey Guy, Stephen Wright, Elizabeth Thiele
  • USE OF CANNABIDIOL IN THE TREATMENT OF EPILEPSY
    Publication number: 20210290565
    Abstract: The present disclosure relates to the use of cannabidiol (CBD) for the treatment of Tuberous Sclerosis Complex (TSC). In particular the TSC is treatment resistant and is characterised by generalised seizures or focal seizures with impairment. The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs).
    Type: Application
    Filed: June 7, 2021
    Publication date: September 23, 2021
    Inventors: Geoffrey GUY, Stephen Wright, Elizabeth Thiele
  • Use of cannabidiol in the treatment of epilepsy
    Patent number: 11065209
    Abstract: The present disclosure relates to the use of cannabidiol (CBD) for the treatment of Tuberous Sclerosis Complex (TSC). In particular the TSC is treatment resistant and is characterised by generalised seizures or focal seizures with impairment. The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs).
    Type: Grant
    Filed: January 12, 2021
    Date of Patent: July 20, 2021
    Assignee: GW Research Limited
    Inventors: Geoffrey Guy, Stephen Wright, Elizabeth Thiele
  • USE OF CANNABIDIOL IN THE TREATMENT OF EPILEPSY
    Publication number: 20210145765
    Abstract: The present disclosure relates to the use of cannabidiol (CBD) for the treatment of Tuberous Sclerosis Complex (TSC). In particular the TSC is treatment resistant and is characterised by generalised seizures or focal seizures with impairment. The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs).
    Type: Application
    Filed: January 12, 2021
    Publication date: May 20, 2021
    Inventors: Geoffrey GUY, Stephen WRIGHT, Elizabeth THIELE
  • Use of cannabidiol in the treatment of epilepsy
    Patent number: 10918608
    Abstract: The present disclosure relates to the use of cannabidiol (CBD) for the treatment of Tuberous Sclerosis Complex (TSC). In particular the TSC is treatment resistant and is characterised by generalised seizures or focal seizures with impairment. The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs).
    Type: Grant
    Filed: October 13, 2015
    Date of Patent: February 16, 2021
    Assignee: GW Research Limited
    Inventors: Geoffrey Guy, Stephen Wright, Elizabeth Thiele
  • USE OF CANNABIDIOL IN THE TREATMENT OF EPILEPSY
    Publication number: 20160166514
    Abstract: The present disclosure relates to the use of cannabidiol (CBD) for the treatment of Tuberous Sclerosis Complex (TSC). In particular the TSC is treatment resistant and is characterised by generalised seizures or focal seizures with impairment. The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs).
    Type: Application
    Filed: October 13, 2015
    Publication date: June 16, 2016
    Inventors: Geoffrey Guy, Stephen Wright, Alice Mead, Elizabeth Thiele